van der Lans RJL, Otten JJ, Adriaensen GFJPM, Hoven DR, et al. Two-year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months. Allergy 2023;78:2684-2697.
PMID: 37394895